Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial. (Q40606333)
Jump to navigation
Jump to search
scientific article published on March 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial. |
scientific article published on March 2001 |
Statements
Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial (English)
A Płuzańska
S Jelic
V Gorbunova
Z Mrsic-Krmpotic
J Berzins
T Nagykalnai
N Wigler
J Renard
S Munier
C Weil
Central & Eastern Europe and Israel Pacitaxel Breast Cancer Study Group